secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2022-12-29T23:59:59+00:00
Accession:  0001575872-22-001373
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

TradeUP Acquisition Corp. stockholders approve extension of business combination deadline to July 19, 2023
--------------------------------------------------------------------------------

- Extension Proposal approved (4,380,625 for, 500 against): extends deadline from Jan 19 to Jul 19, 2023.
- Trust Amendment Proposal approved (4,379,446 for, 1,678 against) to extend liquidation date accordingly.
- Weston Twigg re-elected Class I director with 4,044,959 for, 336,166 withheld.
- Marcum LLP ratified as independent auditor for FY2022: 4,353,040 for, 500 against, 27,585 abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000157587222001373/0001575872-22-001373-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000157587222001373/uptd-20221222.htm
  HTML page:      https://secwatch.observer/filing/0001575872-22-001373

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer